Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

A new study published in the journal Jama estimated that more than 137 million American adults are eligible for medications ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

A recent study published in the Lancet Diabetes & Endocrinology journal states that weight loss drugs can lower kidney ...

A new study shows GLP-1 receptor agonists offer significant protection for kidneys and heart in both diabetic and ...

New research from The George Institute of Global Health shows that a popular class of obesity and type 2 diabetes drugs can ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

A recent study showed that GLP-1 drugs which are beneficial for diabetes and weight loss can also protect your kidneys from ...

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can ...